Figure 13. KQ1 Composite of cardiovascular mortality, nonfatal myocardial infarction and stroke first base case analysis —Meta-analysis of randomized placebo-controlled trials in patients with stable is chemic heart disease.

Figure 13KQ1 Composite of cardiovascular mortality, nonfatal myocardial infarction and stroke first base case analysis —Meta-analysis of randomized placebo-controlled trials in patients with stable is chemic heart disease

Test for heterogeneity: Cochran Q=4.760357 (df=2) p=0.0925

I2 statistic=58%

Note: The squares represent individual point estimates. The size of the square represents the weight given to each study in the meta-analysis. Horizontal lines through each square represent 95% confidence intervals. The diamond represents the combined results. The solid vertical line extending from 1 is the null value.

From: Results

Cover of Comparative Effectiveness of Angiotensin Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers Added to Standard Medical Therapy for Treating Stable Ischemic Heart Disease
Comparative Effectiveness of Angiotensin Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers Added to Standard Medical Therapy for Treating Stable Ischemic Heart Disease [Internet].
Comparative Effectiveness Reviews, No. 18.
Coleman CI, Baker WL, Kluger J, et al.

PubMed Health. A service of the National Library of Medicine, National Institutes of Health.